Si Tuen Lee-Hoeflich
Company: Scholar Rock
Job title: Director, Translational Sciences
Seminars:
Development of a Comprehensive Biomarker Strategy to Support DRAGON, a Phase 1 Clinical Trial of SRK-181, the Latent TGFβ1 Inhibitor 11:00 am
• Preclinical data demonstrate that combining SRK-181 with a PD-1 inhibitor modifies the immune profile within the tumor immune microenvironment • A comprehensive biomarker strategy is being developed to support the ongoing DRAGON trial and further explore the mechanism of action of SRK-181 • Ongoing evaluation of immune biomarkers and establishment of image analysis-based methods…Read more
day: Track B - Day 2 AM